The cardiovascular aspect of COVID-19
AbstractThe coronavirus disease-2019 (COVID-19), an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2), has hit the world very hard by affecting millions of people across countries hence posing a major health threat on a global scale. This novel virus is thought...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2021-01-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2020.1861644 |
| _version_ | 1797385712393256960 |
|---|---|
| author | Joseph Adu-Amankwaah Richard Mprah Adebayo Oluwafemi Adekunle Marie Louise Ndzie Noah Gabriel Komla Adzika Jeremiah Ong’achwa Machuki Hong Sun |
| author_facet | Joseph Adu-Amankwaah Richard Mprah Adebayo Oluwafemi Adekunle Marie Louise Ndzie Noah Gabriel Komla Adzika Jeremiah Ong’achwa Machuki Hong Sun |
| author_sort | Joseph Adu-Amankwaah |
| collection | DOAJ |
| description | AbstractThe coronavirus disease-2019 (COVID-19), an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2), has hit the world very hard by affecting millions of people across countries hence posing a major health threat on a global scale. This novel virus is thought to enter and cause infection in its host through the attachment of its structural protein known as the S-glycoprotein to angiotensin-converting enzyme 2 (ACE2). Given the rapid spread of COVID-19 with its consequences globally, it is mandatory that health caregivers and researchers across all disciplines abreast themselves with the potential effects that this novel virus may have on their fields and the medical society at large. During the infection, the cardiovascular system is affected by unknown pathomechanistic processes, hence accounting for an increased prevalence of cardiovascular diseases (CVDs) among COVID-19 patients. As cardiovascular researchers, we are more concerned about the cardiovascular aspect of SARS-CoV-2/COVID-19. Hence, this concise review addresses these aspects where CVD as a risk factor of COVID-19, the prevalence of CVDs in COVID-19, and the potential cardiovascular disorders which may evolve owing to COVID-19 are discussed. A better understanding of these issues will be pivotal to improve cardiovascular health during this SARS-CoV-2/COVID-19 pandemic and beyond. |
| first_indexed | 2024-03-08T21:58:12Z |
| format | Article |
| id | doaj.art-97cb6a03cdc44f43860f26423f563769 |
| institution | Directory Open Access Journal |
| issn | 0785-3890 1365-2060 |
| language | English |
| last_indexed | 2024-03-08T21:58:12Z |
| publishDate | 2021-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Annals of Medicine |
| spelling | doaj.art-97cb6a03cdc44f43860f26423f5637692023-12-19T16:46:26ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602021-01-0153122723610.1080/07853890.2020.1861644The cardiovascular aspect of COVID-19Joseph Adu-Amankwaah0Richard Mprah1Adebayo Oluwafemi Adekunle2Marie Louise Ndzie Noah3Gabriel Komla Adzika4Jeremiah Ong’achwa Machuki5Hong Sun6Department of Physiology, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaDepartment of Physiology, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaDepartment of Physiology, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaDepartment of Physiology, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaDepartment of Physiology, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaDepartment of Physiology, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaDepartment of Physiology, Xuzhou Medical University, Xuzhou, Jiangsu, ChinaAbstractThe coronavirus disease-2019 (COVID-19), an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2), has hit the world very hard by affecting millions of people across countries hence posing a major health threat on a global scale. This novel virus is thought to enter and cause infection in its host through the attachment of its structural protein known as the S-glycoprotein to angiotensin-converting enzyme 2 (ACE2). Given the rapid spread of COVID-19 with its consequences globally, it is mandatory that health caregivers and researchers across all disciplines abreast themselves with the potential effects that this novel virus may have on their fields and the medical society at large. During the infection, the cardiovascular system is affected by unknown pathomechanistic processes, hence accounting for an increased prevalence of cardiovascular diseases (CVDs) among COVID-19 patients. As cardiovascular researchers, we are more concerned about the cardiovascular aspect of SARS-CoV-2/COVID-19. Hence, this concise review addresses these aspects where CVD as a risk factor of COVID-19, the prevalence of CVDs in COVID-19, and the potential cardiovascular disorders which may evolve owing to COVID-19 are discussed. A better understanding of these issues will be pivotal to improve cardiovascular health during this SARS-CoV-2/COVID-19 pandemic and beyond.https://www.tandfonline.com/doi/10.1080/07853890.2020.1861644SARS-CoV-2COVID-19angiotensin-converting enzyme 2acute respiratory distress syndromecardiovascular disease |
| spellingShingle | Joseph Adu-Amankwaah Richard Mprah Adebayo Oluwafemi Adekunle Marie Louise Ndzie Noah Gabriel Komla Adzika Jeremiah Ong’achwa Machuki Hong Sun The cardiovascular aspect of COVID-19 Annals of Medicine SARS-CoV-2 COVID-19 angiotensin-converting enzyme 2 acute respiratory distress syndrome cardiovascular disease |
| title | The cardiovascular aspect of COVID-19 |
| title_full | The cardiovascular aspect of COVID-19 |
| title_fullStr | The cardiovascular aspect of COVID-19 |
| title_full_unstemmed | The cardiovascular aspect of COVID-19 |
| title_short | The cardiovascular aspect of COVID-19 |
| title_sort | cardiovascular aspect of covid 19 |
| topic | SARS-CoV-2 COVID-19 angiotensin-converting enzyme 2 acute respiratory distress syndrome cardiovascular disease |
| url | https://www.tandfonline.com/doi/10.1080/07853890.2020.1861644 |
| work_keys_str_mv | AT josephaduamankwaah thecardiovascularaspectofcovid19 AT richardmprah thecardiovascularaspectofcovid19 AT adebayooluwafemiadekunle thecardiovascularaspectofcovid19 AT marielouisendzienoah thecardiovascularaspectofcovid19 AT gabrielkomlaadzika thecardiovascularaspectofcovid19 AT jeremiahongachwamachuki thecardiovascularaspectofcovid19 AT hongsun thecardiovascularaspectofcovid19 AT josephaduamankwaah cardiovascularaspectofcovid19 AT richardmprah cardiovascularaspectofcovid19 AT adebayooluwafemiadekunle cardiovascularaspectofcovid19 AT marielouisendzienoah cardiovascularaspectofcovid19 AT gabrielkomlaadzika cardiovascularaspectofcovid19 AT jeremiahongachwamachuki cardiovascularaspectofcovid19 AT hongsun cardiovascularaspectofcovid19 |